Form 4: Axogen Director Paul Thomas Reports Stock Vesting

Director Paul Thomas reports the vesting of 11,904 restricted stock units of Axogen, Inc. on September 1, 2024.

Summary

• Paul Thomas, a director of Axogen, Inc., reported a transaction on September 1, 2024.
• The transaction involved the vesting of 11,904 restricted stock units, which converted into common stock.
• Following the transaction, Thomas directly owns 32,052 shares of Axogen common stock.
• The vesting of the restricted stock units was part of an annual equity grant for service as a Director on the Axogen, Inc. Board of Directors.
• The equity grant was valued at $150,000 as of the grant date and vested on the one-year anniversary of the grant date.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.

Positives

• The vesting of restricted stock units indicates continued service and commitment of the director to the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The vesting of stock units aligns the director's interests with those of the shareholders.

Key Dates